GENA-104A16
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GENA-104A16, covering 2025-07-17 to 2025-07-17. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors [Phase 1]